Literature DB >> 16869342

Current understanding of the mechanisms of gastro-oesophageal reflux disease.

Roy C Orlando1.   

Abstract

Gastro-oesophageal reflux disease (GERD) covers a broad range of signs and symptoms arising from the orad movement of gastric contents into the oesophagus, oropharynx, larynx or airway. Most commonly, contact with and damage to the oesophageal epithelium by acidic refluxate causes micro or macroscopic defects leading to the symptom of heartburn. However, GERD can also give rise to extra-oesophageal manifestations such as pharyngitis, laryngitis, asthma and other disorders, identifiable as acid-mediated events by a favorable response to acid suppression. Only one-third of individuals with heartburn have endoscopic evidence of erosive oesophagitis; the remainder have endoscopy-negative or non-erosive reflux disease (NERD). Improved investigative technologies are increasing our understanding of the pathophysiology of NERD. For example, although a number of microscopic abnormalities have been identified, oesophageal damage in NERD has been shown to be characterized by the presence of 'dilated intercellular spaces' within oesophageal stratified squamous epithelium. Dilated intercellular spaces that reflect damage to the intercellular junctions enable levels of acidity that would be considered innocuous when present in the oesophageal lumen to initiate pathological responses within oesophageal nociceptors when present within the intercellular spaces. This effectively gives rise to the symptom of heartburn. Excessive acidity within the intercellular spaces in NERD also presages its evolution to erosive disease, the latter through inflammation-mediated disruption of the antireflux and luminal clearance mechanisms. Support for this scenario is evident by the ability of effective acid control with proton pump inhibitors both to control symptoms, and lead to resolution of dilated intercellular spaces in patients with both erosive and non-erosive disease. This article examines these concepts and how they shape our current understanding of GERD.

Entities:  

Mesh:

Year:  2006        PMID: 16869342     DOI: 10.2165/00003495-200666001-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  7 in total

Review 1.  The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis.

Authors:  William J Barlow; Roy C Orlando
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

2.  Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment.

Authors:  Carlo Calabrese; Mauro Bortolotti; Anna Fabbri; Alessandra Areni; Giovanna Cenacchi; Carlo Scialpi; Mario Miglioli; Giulio Di Febo
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

3.  Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.

Authors:  F Pace; S Bollani; P Molteni; G Bianchi Porro
Journal:  Dig Liver Dis       Date:  2004-02       Impact factor: 4.088

4.  Differential pH and capsaicin responses of Griffonia simplicifolia IB4 (IB4)-positive and IB4-negative small sensory neurons.

Authors:  M Liu; N J Willmott; G J Michael; J V Priestley
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

5.  Appropriate acid suppression for the management of gastro-oesophageal reflux disease.

Authors:  N J Bell; D Burget; C W Howden; J Wilkinson; R H Hunt
Journal:  Digestion       Date:  1992       Impact factor: 3.216

6.  Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication.

Authors:  J B So; S M Zeitels; D W Rattner
Journal:  Surgery       Date:  1998-07       Impact factor: 3.982

Review 7.  Gastroesophageal reflux disease--should we adopt a new conceptual framework?

Authors:  Ronnie Fass; Joshua J Ofman
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

  7 in total
  11 in total

1.  Crying in infant GERD: acid or volume? Heartburn or dyspepsia?

Authors:  Susan R Orenstein
Journal:  Curr Gastroenterol Rep       Date:  2008-10

2.  Quality of life in GERD and Barrett's esophagus is related to gender and manifestation of disease.

Authors:  Quinn K Lippmann; Seth D Crockett; Evan S Dellon; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2009-09-15       Impact factor: 10.864

3.  Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease.

Authors:  Biljana Jovov; Jianwen Que; Nelia A Tobey; Zorka Djukic; Brigid L M Hogan; Roy C Orlando
Journal:  Am J Gastroenterol       Date:  2011-03-29       Impact factor: 10.864

Review 4.  Dexlansoprazole modified release: in erosive oesophagitis and non-erosive reflux disease.

Authors:  Jamie D Croxtall; Lesley J Scott
Journal:  Drugs       Date:  2010-08-20       Impact factor: 9.546

5.  Factors influencing intercellular spaces in the rat esophageal epithelium.

Authors:  Dong-Hong Zhang; Li-Ya Zhou; Xiu-Yun Dong; Rong-Li Cui; Yan Xue; San-Ren Lin
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

6.  Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease.

Authors:  J Arts; D Sifrim; P Rutgeerts; A Lerut; J Janssens; J Tack
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

7.  Symptoms and reflux in infants: Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-R)--utility for symptom tracking and diagnosis.

Authors:  Susan R Orenstein
Journal:  Curr Gastroenterol Rep       Date:  2010-12

Review 8.  Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.

Authors:  Dilawar Khokhar; Sahiti Marella; Gila Idelman; Joy W Chang; Mirna Chehade; Simon P Hogan
Journal:  Clin Exp Allergy       Date:  2022-07-19       Impact factor: 5.401

Review 9.  The concept of complete remission of gastro-oesophageal reflux disease : comparative efficacy of pantoprazole and esomeprazole using the ReQuest questionnaire.

Authors:  Alan B R Thomson
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 10.  Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease.

Authors:  George Triadafilopoulos
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.